The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non ‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database
ConclusionsThe results showed that the efficacy of molecular-targeted agents as first-line therapy was similar oncological outcomes between metastatic nccRCC and ccRCC in Japanese patients. TKIs may be more effective than mTORIs in metastatic nccRCC patients. Nivolumab administration might also be as effective in nccRCC patients as in ccRCC patients in Japanese population.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tomoyuki Koguchi,
Sei Naito,
Shingo Hatakeyama,
Kazuyuki Numakura,
Yumina Muto,
Renpei Kato,
Takahiro Kojima,
Yoshihide Kawasaki,
Kento Morozumi,
Shuya Kandori,
Sadafumi Kawamura,
Hiroyuki Nishiyama,
Akihiro Ito,
Tomonori Habuchi,
Wataru Oba Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Cytokine Therapy | Databases & Libraries | Japan Health | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology